Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis 2022-04-04 21:31
Ascletis Announces Completion of First Sale of Its Ritonavir Tablets in Zhejiang Province 2022-04-04 17:10
SeaX Ventures Launches $60 Million Fund II to Help International Startups Expand in Southeast Asia 2022-04-04 16:00
B.I.G. VISION® FOR ALL from Rodenstock: Optimal vision with biometric lenses for everyone 2022-04-04 15:48
CanSinoBIO's COVID-19 mRNA Vaccine Receives Approval of Clinical Trial Application in China 2022-04-04 08:30
Innovent Releases Results of a Phase 3 Clinical Study of IBI306 (PCSK-9 inhibitor) in Chinese Patients with Heterozygous Familial Hypercholesterolemia at the American College of Cardiology Annual Congress 2022 2022-04-04 08:00
Commercial Launch: Illuccix® Now Available to Order in the United States 2022-04-04 07:06
Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting 2022-04-01 23:45
Novavax Submits Request to Expand Conditional Marketing Authorization of COVID-19 Vaccine in the European Union to Adolescents (Ages 12-17) 2022-03-31 18:00
Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD) 2022-03-31 17:00
CStone announces first patient enrollment in the U.S. in the Phase 1 clinical trial of CS5001, a potential global best-in-class ROR1-targeting ADC 2022-03-31 08:02
Symbiance announces the launch of SimpleStats, an application for statistical analysis and reporting of clinical data 2022-03-30 21:00
GenScript Receives "Best Contract Development and Manufacturing Organization Award" For the Third Time in a Row 2022-03-30 17:30
BioVaxys Expands Cancer Vaccine Platform 2022-03-30 16:02
Qiming's Portfolio Company Rendu Biotechnology Lists on STAR Market 2022-03-30 10:22
Antengene Announces IND Approval in China for a Phase II Study of Eltanexor (ATG-016) in Patients with High-Risk Myelodysplastic Syndromes 2022-03-30 09:00
RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines 2022-03-30 08:31
Brii Bio Announces Strategic Partnership with Sinopharm to Advance Commercialization of Long-Acting COVID-19 Neutralizing Antibody Therapy, Amubarvimab/Romlusevimab Combination, in China 2022-03-30 08:05
Daewoong Pharmaceutical submitted NDA for its global new drug Fexuclue Tablets to the Philippines 2022-03-29 09:00
ILC Dover Announces Liquid Single-Use Bioprocessing Bags for Rapidly Growing Biotherapeutics and Cell & Gene Therapy Markets 2022-03-29 05:11
1 80 81 82 83 84 212